Hefner, Gudrun http://orcid.org/0000-0001-5892-8993
Wolff, Jan
Toto, Sermin
Reißner, Pamela
Klimke, Ansgar
Funding for this research was provided by:
DLR (study number 01VSF16009)
Article History
Received: 8 August 2022
Accepted: 30 August 2022
First Online: 7 September 2022
Declarations
:
: Gudrun Hefner, Jan Wolff, Pamela Reißner, and Ansgar Klimke declare no conflicts of interest/competing interests. Sermin Toto is a member of the advisory board for Janssen-Cilag and Otsuka and has received speaker’s honoraria from Janssen-Cilag, Lundbeck/Otsuka, Recordati Pharma GmbH, and Servier.
: Ethical approval was obtained in November 2017 in Hesse, Germany; reference number: FF 116/2017.
: All authors consent to participate in this study and for publication of the study results.